Overview of partial compliance
- PMID: 14680412
Overview of partial compliance
Abstract
A substantial proportion of patients with psychiatric and nonpsychiatric chronic illnesses fail to take their medications as prescribed. A number of studies suggest that 50% or more of individuals with schizophrenia are noncompliant with medications at some time during their illness. In most cases, patients are partially compliant, taking only a portion of their prescribed medications. Noncompliance is probably the most important element contributing to relapse in schizophrenia. Factors contributing to the rate of noncompliance include medication side effects, the severity of psychotic symptoms, impaired cognition, and an inadequate understanding of the role of medication for preventing relapse. In addition, both patients and clinicians overestimate patients' compliance. Strategies for managing partial compliance include the treatment of medication side effects, the education of patients about their illness, and the use of long-acting antipsychotic formulations.
Similar articles
-
Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies.J Clin Psychiatry. 2003;64 Suppl 16:34-40. J Clin Psychiatry. 2003. PMID: 14680417 Review.
-
[Which factors modify drug-compliance?].Psychiatr Prax. 1995 Nov;22(6):228-30. Psychiatr Prax. 1995. PMID: 8570752 German.
-
Review of treatments that can ameliorate nonadherence in patients with schizophrenia.J Clin Psychiatry. 2006;67 Suppl 5:9-14. J Clin Psychiatry. 2006. PMID: 16822091 Review.
-
Partial compliance with antipsychotic medication is common in patients with schizophrenia.Aust N Z J Psychiatry. 2008 May;42(5):382-8. doi: 10.1080/00048670801961107. Aust N Z J Psychiatry. 2008. PMID: 18473256
-
Choice of maintenance medication for schizophrenia.J Clin Psychiatry. 2003;64 Suppl 16:24-33. J Clin Psychiatry. 2003. PMID: 14680416 Review.
Cited by
-
Heterogeneity of Treatment Effects of Long-Acting Injectable Antipsychotic Medications.J Clin Psychiatry. 2018 Nov 27;80(1):18m12109. doi: 10.4088/JCP.18m12109. J Clin Psychiatry. 2018. PMID: 30549494 Free PMC article. Clinical Trial.
-
Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.Psychopharmacology (Berl). 2006 Aug;187(2):229-36. doi: 10.1007/s00213-006-0413-4. Epub 2006 May 19. Psychopharmacology (Berl). 2006. PMID: 16710714
-
Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients.BMC Psychiatry. 2009 Jul 29;9:46. doi: 10.1186/1471-244X-9-46. BMC Psychiatry. 2009. PMID: 19640279 Free PMC article.
-
Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics.Clin Drug Investig. 2021 Jan;41(1):99-113. doi: 10.1007/s40261-020-00990-8. Epub 2020 Dec 17. Clin Drug Investig. 2021. PMID: 33331979 Free PMC article.
-
Cognitive impairment as determinant for sub-optimal control of oral anticoagulation treatment in elderly patients with atrial fibrillation.Drugs Aging. 2005;22(4):353-60. doi: 10.2165/00002512-200522040-00007. Drugs Aging. 2005. PMID: 15839723 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical